![Maria Ekblad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Ekblad
Directeur Technique/Scientifique/R&D chez
FOLLICUM AB (PUBL)
Profil
Maria Ekblad currently works at Follicum AB, as Director-Research & Development from 2016 and Iconovo AB, as Head-Generics Development from 2023.
Ms. Ekblad also formerly worked at Aptahem AB, as Chief Operating Officer from 2022 to 2023.
Ms. Ekblad received her graduate degree from the University of Lund.
Postes actifs de Maria Ekblad
| Sociétés | Poste | Début |
|---|---|---|
| FOLLICUM AB (PUBL) | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| ICONOVO AB | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Maria Ekblad
| Sociétés | Poste | Fin |
|---|---|---|
| APTAHEM AB | Directeur des opérations | 01/10/2023 |
Formation de Maria Ekblad
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for the treatment of hair-loss | Health Technology |
Iconovo AB
 Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Engages in the pharmaceutical businesses, which research and develops medicines for treating and preventing diseases caused by blockage of blood vessels, such as deep vein thrombosis, stroke and heart failure | Health Technology |
